Investment House LLC Biogen Inc. Transaction History

Investment House LLC

$1.75 Billion
Q2 2024

A detailed history of Investment House LLC transactions in Biogen Inc. stock. As of the latest transaction made, Investment House LLC holds 3,269 shares of BIIB stock, worth $639,514. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,269

Previous 3,269 -0.0%

Holding current value

$639,514

Previous $704,000 7.53%

% of portfolio

0.04%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$222.59 - $267.94 $14,913 - $17,951	-67 Reduced 2.01%	3,269 $845,000
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $25,330 - $28,589	100 Added 3.09%	3,336 $857,000
Q2 2023 Aug 08, 2023	SELL	$275.25 - $318.06 $116,706 - $134,857	-424 Reduced 11.58%	3,236 $921,000
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $10,707 - $14,765	-55 Reduced 1.48%	3,660 $977,000
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $51,010 - $60,661	-272 Reduced 6.82%	3,715 $758,000
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $22,283 - $28,076	-115 Reduced 2.8%	3,987 $840,000
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $22,392 - $28,777	-100 Reduced 2.38%	4,102 $984,000
Q1 2021 May 06, 2021	SELL	$242.95 - $284.63 $295,184 - $345,825	-1,215 Reduced 22.43%	4,202 $1.18 Million
Q4 2020 Jan 13, 2021	SELL	$236.26 - $355.63 $241,457 - $363,453	-1,022 Reduced 15.87%	5,417 $1.33 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $19,857 - $22,928	-75 Reduced 1.15%	6,439 $1.83 Million
Q2 2020 Jul 13, 2020	SELL	$258.66 - $342.55 $19,399 - $25,691	-75 Reduced 1.14%	6,514 $1.74 Million
Q1 2020 Apr 08, 2020	SELL	$268.85 - $341.04 $70,707 - $89,693	-263 Reduced 3.84%	6,589 $2.09 Million
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $32,568 - $45,002	-148 Reduced 2.11%	6,852 $2.03 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $332,248 - $372,648	-1,528 Reduced 17.92%	7,000 $1.63 Million
Q2 2019 Aug 05, 2019	BUY	$219.29 - $241.72 $313,803 - $345,901	1,431 Added 20.16%	8,528 $1.99 Million
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $11,919 - $18,642	-55 Reduced 0.77%	7,097 $1.68 Million
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $993,688 - $1.26 Million	-3,568 Reduced 33.28%	7,152 $2.15 Million
Q3 2018 Oct 09, 2018	SELL	$293.51 - $383.83 $139,710 - $182,703	-476 Reduced 4.25%	10,720 $3.79 Million
Q2 2018 Jul 10, 2018	BUY	$257.52 - $306.91 $47,898 - $57,085	186 Added 1.69%	11,196 $3.25 Million
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $1,300 - $1,839	-5 Reduced 0.05%	11,010 $3.02 Million
Q4 2017 Jan 31, 2018	SELL	$307.64 - $344.58 $209,810 - $235,003	-682 Reduced 5.83%	11,015 $3.51 Million
Q3 2017 Oct 30, 2017	BUY	$281.15 - $329.69 $3.29 Million - $3.86 Million	11,697	11,697 $3.66 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Account

Investment House LLC Biogen Inc. Transaction History